Pune, India, December , 2017/MRFR Press Release/- Market Research Future published a Cooked research report on “Global Diabetes Monitors Market Research Report - Forecast to 2023” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.
Global Diabetes Monitors Market - Overview
The global diabetes monitors market is growing mainly due to the technological advancements. According to a recent study report published by the Market Research Future, The global diabetes monitors market is booming and expected to gain prominence over the forecast period. The market is forecasted to demonstrate a spectacular growth by 2023, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2023).
Monitoring glucose level is expected to prolong life expectancy as it enables the management of hypo- or hyperglycaemia. Self-monitoring method is most commonly used to check blood glucose level. The method involves sampling blood from a finger or any other body part, to be analysed with the help of test strips and a glucometer. Although blood remains the most commonly used sample, other biological fluids such as ocular fluid, sweat, breath, interstitial fluid, saliva or urine can also be used as an alternative samples for non-invasive continuous monitoring. Glucose monitoring is used to optimize treatment strategies, and provide an insight to the effect of diet, medications, and exercise on the patient.
Notably, increasing technological advancement is the key factor driving the diabetes monitors market. For instance, due to increasing acceptance of CGM systems multitude of products have been introduced by leading players, such as Medtronic Diabetes Guardian Real-Time, DexCom G4 Platinum, MedtroniMiniMed Paradigm Real-Time Revel, and others.
Other factors such as, rise in prevalence of diabetes, huge research funding in diabetes diagnosis and treatment, rising approval from regulatory bodies, and increasing global prevalence of obesity are also fuelling the market growth.
Despite these drivers, stringent reimbursement policies, and cost associated with treatment are expected to decline the market growth.
On considering the recent trends, it is observed that continuous glucose monitoring (CGM) devices are gaining popularity across the globe. However, high cost of device is still an area of concern.
Global Diabetes Monitors Market - Competitive Analysis
Panasonic (Japan), Abbott Laboratories (U.S.), Dexcom, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Medtronic (U.S.), LifeScan, Inc. (U.S.), Sanofi (France), are some of the prominent players at the forefront of competition in the diabetes monitors market and are profiled in MRFR Analysis.
The global diabetes monitors market is currently dominated by few players.
Abbott Laboratories is one of them by holding a strong share in the market. The company is a global leader that develops and manufactures pharmaceuticals and medical products. The prime emphasis of the company is on production of innovative products. For instance, in 2016, Abbott launched two apps in Europe for FreeStyle Libre i.e. LibreLink, and LibreLinkUp, and received FDA approval for FreeStyle Libre Pro. In the year 2014, Abbott Received European approval to launch the Freestyle Libre System. Further, the company has also invested heavily in various research and development activities to bring innovative products in the market and to cater to the unmet market needs.
LifeScan, Inc. is also one of the leading player in diabetes monitors market. The company’s stronghold is largely attributed to its innovative and sustainable products. LifeScan, Inc. operates as a subsidiary of Johnson & Johnson. In 2016, to sustain its place in the diabetes monitors market, the company has entered a strategic agreement with WellDoc Corporation to advance Mobile Care Solutions for Type 2 Diabetes Patients, and in the same year company has launched Bluetooth-enabled OneTouch Verio Flex blood glucose meter.
Merging, and acquisitions have become a key to sustain in the market for various marketers. On Sep 12, 2016, Sanofi teamed up with Verily Life Sciences to launch Onduo. It is a diabetes-focused Joint Venture.
Browse Full Report @ https://www.marketresearchfuture.com/reports/diabetes-monitors-market-4781
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Report details
| Companies Covered | 15 |
| Pages | 85 |
Certified Global Research Member
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
